U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07053670) titled 'A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG11001 )' on June 27.
Brief Summary: A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma.
Study Start Date: July 11
Study Type: INTERVENTIONAL
Condition:
B-Cell Non-Hodgkin Lymphoma
Intervention:
DRUG: CAR T cells
chimeric antigen receptor T cells
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tongji Hospital
Information provided by (Responsible Party): Yicheng Zhang, Tongji ...